*/
Patent – Infringement. The defendant company, Lilly, produced a cancer treatment marketed under the name Alimta. The claimant companies sought to produce a generic product and obtain regulatory approval for it by reference to Alimta. Lilly contended that doing so would infringe its patent. The Patents Court considered the issue with regard to the United Kingdom, France, Italy and Spain, and held that the claimant companies were entitled to a declaration of non-infringement concerning all of the jurisdictions in question.
Patent – Infringement. The defendant company, Lilly, produced a cancer treatment marketed under the name Alimta. The claimant companies sought to produce a generic product and obtain regulatory approval for it by reference to Alimta. Lilly contended that doing so would infringe its patent. The Patents Court considered the issue with regard to the United Kingdom, France, Italy and Spain, and held that the claimant companies were entitled to a declaration of non-infringement concerning all of the jurisdictions in question.
Efforts continue on gender equality, support for the Bar, meaningful reform for the sector and advocating for the rule of law
To mark International Women’s Day, Louise Crush of Westgate Wealth Management looks at how financial planning can help bridge the gap
Casey Randall of AlphaBiolabs answers some of the most common questions regarding relationship DNA testing for court
Leading drug, alcohol and DNA testing laboratory AlphaBiolabs has made a £500 donation to Beatson Cancer Charity in Glasgow as part of its Giving Back campaign
Girls Human Rights Festival 2025: a global gathering for change
Exclusive Q&A with Henry Dannell
